Evidence map›Paper›PMID 26002230›Full record

ArticleJournal of anesthesia2015

Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α.

Hua Liang, Cheng Xiang Yang, Bin Zhang, Han Bing Wang, Hong Zhen Liu, Xiao Hong Lai, Mei Juan Liao, Tao Zhang

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Journal of anesthesia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02660411 nacompletednot on this map

Impact of Inhalational Versus Intravenous Anesthesia Maintenance Methods on Long-term Survival in Elderly Patients After Cancer Surgery: a Randomized Controlled Trial

TypeinterventionalSponsorPeking University First HospitalRan2015 to 2020Enrolled1,228ConditionsAged, Neoplasms, Surgical Procedure, Operative, Anesthesia, InhalationArmsSevoflurane, Propofol
NCT05343260 nacompletednot on this map

Impact of Inhalational Versus Intravenous Anesthesia Maintenance Methods on 5-year Survival in Elderly Patients After Cancer Surgery: a Randomized Controlled Trial

TypeinterventionalSponsorPeking University First HospitalRan2015 to 2023Enrolled1,228ConditionsAged, Neoplasms, Surgical Procedure, Operative, Anesthesia, InhalationArmsSevoflurane, Propofol
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Sevoflurane induces CaCytotechnology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hua LiangDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China. lhlh2003@126.com.
Cheng Xiang YangDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China.
Bin ZhangDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China.
Han Bing WangDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China.
Hong Zhen LiuDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China.
Xiao Hong LaiDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China.
Mei Juan LiaoDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China.
Tao ZhangDepartment of Anesthesiology, Affiliated FoShan Hospital of SUN YAT-SEN University, 528000, Foshan, China.
Sun Yat-sen University · CNFoshan Hospital of TCM · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHypoxia promotes the progression of lung cancer cells. Unfortunately, anesthetic technique might aggravate hypoxia of lung cancer cells. Sevoflurane is a commonly used anesthetic. Its effect on hypoxia-induced aggressiveness of lung cancer cells remains unknown. The aim of the study is to investigate the effects of sevoflurane on hypoxia-induced growth and metastasis of lung cancer cells. As hypoxia-inducible factor-1α (HIF-1α) plays a pivotal role in mediating the adaptation and tolerance of cancer cells under hypoxic microenvironment, the role of HIF-1α in the effect of sevoflurane on hypoxia-induced growth and metastasis has also been elucidated.

methodsA549 cells were treated with normoxia, hypoxia, co-treatment of sevoflurane and hypoxia, and dimethyloxaloylglycine (DMOG, a HIF-1α agonist) for 4 h, respectively. MTT assay and colony formation assay were used to evaluate cell growth. Transwell assay was performed to detect invasion and migration ability. The protein level of HIF-1α, X-linked inhibitor of apoptosis protein (XIAP), survivin, fascin, heparanase (HPA), and p38 MAPK were determined by Western blotting.

resultsHypoxia enhanced proliferation and metastatic potential of cells. Sevoflurane could suppress hypoxia-induced growth and metastasis ability of cells. Furthermore, HIF-1α, XIAP, survivin, fascin and HPA were down-regulated significantly by the co-treatment of sevoflurane and hypoxia as compared to hypoxia treatment. DMOG abolished the inhibiting effects of sevoflurane on hypoxia-induced growth and metastasis ability of cells. In addition, sevoflurane partly reversed the increase of p38 MAPK activity that was induced by hypoxia.

conclusionsSevoflurane could suppress hypoxia-induced growth and metastasis of lung cancer cells, which might be associated with modulating HIF-1α and its down-stream genes. Moreover, p38 MAPK signaling pathway was involved in the regulation of HIF-1α by sevoflurane.

Indexed as

Cell HypoxiaCell Line, TumorCell ProliferationDown-RegulationHumansHypoxia-Inducible Factor 1, alpha SubunitLung NeoplasmsMethyl Ethersp38 Mitogen-Activated Protein KinasesSevofluraneSignal TransductionX-Linked Inhibitor of Apoptosis ProteinHypoxia-Inducible Factor 1, alpha SubunitMethyl Ethersp38 Mitogen-Activated Protein KinasesSevofluraneXIAP protein, humanX-Linked Inhibitor of Apoptosis ProteinHypoxia-inducible factor-1αLung cancer cellsSevoflurane

Identifiers

PMID26002230
OpenAlexW264427262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.